Therapeutic Area Global Expert Statistician - CNS %26 Retinopathies
US-BI Pharma/BI USA
 CT (Connecticut)

Description:

Represents the

statistical function in the Therapeutic Area (TA) CNS and Retinopathies and is

accountable for all major statistical decisions affecting clinical development

for the entire CNS & Retinopathies drug portfolio.

The position

can be located in Germany (Ingelheim or Biberach) or in the United States

(Ridgefield in Connecticut).

Arial;mso-fareast-language:ZH-CN;mso-bidi-language:TH“>

Arial;mso-fareast-language:ZH-CN;mso-bidi-language:TH“>As an employee of

Boehringer Ingelheim, you will actively contribute to the discovery,

development and delivery of our products to our patients and customers. Our

global presence provides opportunity for all employees to collaborate

internationally, offering visibility and opportunity to directly contribute to

the companies' success. We realize that our strength and competitive advantage

lie with our people. We support our employees in a number of ways to foster a

healthy working environment, meaningful work, diversity and inclusion,

mobility, networking and work-life balance. Our competitive compensation and

benefit programs reflect Boehringer Ingelheim's high regard for our employees.

Arial;mso-fareast-language:ZH-CN;mso-bidi-language:TH“>

Duties &

Responsibilities:

  • As a TA
    Global Expert Statistician for the TAs CNS, Retinopathies and Emerging Disease
    Areas you will:
  • Be a member
    of strategic TA Committees and act as the go-to-partner on statistical topics
    for the TA Head of Medicine and TA-representatives from other functions.
  • Direct,
    mentor and support Project Statisticians in CNS-diseases and Retinopathies to
    ensure that clinical development plans and trial protocols are built on
    state-of-art statistical-methodology and meet regulatory requirements.
  • Provide
    statistical expert support on regulatory interactions for clinical development
    projects in the TA.
  • Lead the
    growth of the global TA Statistics Organization and be accountable to provide a
    platform for scientific exchange, collaboration and accumulation of TA disease
    & drug knowledge.
  • Lead the
    development and oversee the application of TA standards for statistical methods
    as well as support the Global Head Statistics and the Global Head Methodology
    Statistics on BI standards for statistical methods.
  • Provide
    statistical leadership and develop strategic directions for BI Statistics and
    facilitate collaboration experience exchange and scientific growth across TAs.
  • Build strong
    partnership with academic, regulatory and industry expert statisticians and
    KOLs in the TA to bring in state-of-art statistical methodologies, critical
    trial design ideas and development strategies to BI.

Requirements:

  • Doctoral degree from an accredited institution, plus ten
    (10) years of experience working within the pharmaceutical industry, CROs,
    regulatory authorities or academic institutions; OR
  • Master’s degree from an accredited institution, plus fifteen
    (15) years of experience within the pharmaceutical industry, CROs, regulatory
    authorities or academic institutions
  • Record of presentations at international conferences and
    publications in clinical trials and/or statistical methodology in high-level
    journals
  • Extensive experience with communication and presentation of
    statistical information to internal and bodies (specialists and
    non-specialists)
  • Demonstrated ability to critique devised hypotheses and
    results interpretation on multiple occasions in discussions with KOLs and/or
    regulatory agencies
  • Evidence of strong teamwork at trial and project level and
    extensive experience with supervision and mentoring staff
  • Demonstrated ability to initiate and lead successfully
    international interdisciplinary project teams or working groups
  • Represented a company or academic institution successfully
    in across industry working groups or initiatives
  • Experience in regulatory interactions and negotiations with
    external decision making bodies for multiple projects
  • MSTAT: Experience in implementing complex innovative
    statistical methods and tools for usage at trials and project level across
    different methodological and therapeutic areas
  • Experience in organizing and providing training and/or
    lectures on statistical methodology

Eligibility

Requirements:

  • Must be legally
    authorized to work in the United States without restriction.
  • Must be willing to
    take a drug test and post-offer physical (if required).
  • Must be 18 years of
    age or older.

Who We Are:

At Boehringer Ingelheim we create value through innovation

with one clear goal: to improve the lives of patients. We develop breakthrough

therapies and innovative healthcare solutions in areas of unmet medical need

for both humans and animals. As a family owned company we focus on long term

performance. We are powered by 50.000 employees globally who nurture a

diverse, collaborative and inclusive culture. Learning and development for

all employees is key because your growth is our growth.

Want to learn more? Visit

boehringer-ingelheim.com and

join us in our effort to make more health.

Boehringer

Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer

Ingelheim USA, Boehringer Ingelheim Animal Health USA Inc., Boehringer

Ingelheim Animal Health Puerto Rico LLC and Boehringer Ingelheim Fremont,

Inc. is an equal opportunity and affirmative action employer committed to

a culturally diverse workforce. All qualified applicants will receive

consideration for employment without regard to race; color; creed; religion;

national origin; age; ancestry; citizenship status, marital, domestic

partnership or civil union status; gender, gender identity or expression;

affectional or sexual orientation; pregnancy, childbirth or related medical

condition; physical or psychiatric disability; veteran or military status;

domestic violence victim status; genetic information (including the refusal to

submit to genetic testing) or any other characteristic protected by applicable

federal, state or local law.